Newsletter

196170 - Alteogen Inc.

196170 Summary
Biopharma
Stock Price & Overview
₩288,500 +5,500 (+1.94%) Close · Sep 4, 2026 KST
KOSDAQ | ₩KRW | Close: ₩288,500  ≈ US$206  ·  Market cap ₩20.1tn (≈ $14.4bn)
Home › 196170 › Filings

Record date set, shareholder register closed

DART
Alteogen Inc.
Filed Jul 16, 2026 KST · Filing · receipt 20260716900638

kstock has not written this one up. The title above is a translation of the Korean form name; the filing itself is on DART, in Korean.

Read the original on DART ↗ Korean. DART is Korea's electronic disclosure system, run by the Financial Supervisory Service — the filing equivalent of EDGAR.
Korean form name: 주주명부폐쇄기간또는기준일설정

196170

Price
₩288,500
Change
+1.94%
Market cap
₩20.1tn
Prev. close
₩283,000
196170 SummaryCompare to Peers

More 196170 filings

Alteogen Signs Exclusive Option-License Deal With Novartis for ALT-B4 Hyaluronidase, Worth Up to $3.22 Billion

09/02/26

Alteogen to Collect $25 Million Sales Milestone From MSD Under ALT-B4 License

08/31/26

New Facility Investment

08/21/26

Half-Year Report

08/14/26

Insider / Major Shareholder Holdings Report ×4

08/13/26

Preliminary Consolidated Results (Fair Disclosure)

08/07/26